136 related articles for article (PubMed ID: 36419212)
21. Design, synthesis and cholinesterase inhibitory properties of new oxazole benzylamine derivatives.
Šagud I; Maček Hrvat N; Grgičević A; Čadež T; Hodak J; Dragojević M; Lasić K; Kovarik Z; Škorić I
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):460-467. PubMed ID: 31899981
[TBL] [Abstract][Full Text] [Related]
22. Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes.
Gülçin İ; Scozzafava A; Supuran CT; Koksal Z; Turkan F; Çetinkaya S; Bingöl Z; Huyut Z; Alwasel SH
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1698-702. PubMed ID: 26864149
[TBL] [Abstract][Full Text] [Related]
23. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
24. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
[TBL] [Abstract][Full Text] [Related]
27. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds.
Bora RE; Genc Bilgicli H; Üç EM; Alagöz MA; Zengin M; Gulcin İ
Chem Biol Interact; 2022 Oct; 366():110134. PubMed ID: 36057360
[TBL] [Abstract][Full Text] [Related]
29. Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase.
Pohanka M; Dobes P
Int J Mol Sci; 2013 May; 14(5):9873-82. PubMed ID: 23698772
[TBL] [Abstract][Full Text] [Related]
30. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
31. The effect of caffeic acid phenethyl ester (CAPE) on metabolic enzymes including acetylcholinesterase, butyrylcholinesterase, glutathione S-transferase, lactoperoxidase, and carbonic anhydrase isoenzymes I, II, IX, and XII.
Gülçin İ; Scozzafava A; Supuran CT; Akıncıoğlu H; Koksal Z; Turkan F; Alwasel S
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1095-101. PubMed ID: 26453427
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors.
Ekiz M; Tutar A; Ökten S; Bütün B; Koçyiğit ÜM; Taslimi P; Topçu G
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800167. PubMed ID: 30079554
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone.
Ozçelik AB; Gökçe M; Orhan I; Kaynak F; Sahin MF
Arzneimittelforschung; 2010; 60(7):452-8. PubMed ID: 20712136
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, design, and assessment of novel morpholine-derived Mannich bases as multifunctional agents for the potential enzyme inhibitory properties including docking study.
Boy S; Türkan F; Beytur M; Aras A; Akyıldırım O; Karaman HS; Yüksek H
Bioorg Chem; 2021 Feb; 107():104524. PubMed ID: 33317836
[TBL] [Abstract][Full Text] [Related]
35. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
[TBL] [Abstract][Full Text] [Related]
36. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
37. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potent carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase enzymes inhibitors: The new amides and thiazolidine-4-ones synthesized on an acetophenone base.
Taslimi P; Osmanova S; Gulçin İ; Sardarova S; Farzaliyev V; Sujayev A; Kaya R; Koc F; Beydemir S; Alwasel SH; Kufrevioglu OI
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544359
[TBL] [Abstract][Full Text] [Related]
39. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
40. Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates.
Krátký M; Štěpánková Š; Vorčáková K; Švarcová M; Vinšová J
Molecules; 2016 Feb; 21(2):. PubMed ID: 26875979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
